Selective toxic effects of tamoxifen on osteoclasts: comparison with the effects of oestrogen
- PMID: 8691109
- DOI: 10.1677/joe.0.1490503
Selective toxic effects of tamoxifen on osteoclasts: comparison with the effects of oestrogen
Abstract
We investigated the actions of the trans- and cis-isomers of tamoxifen on the function of neonatal rat osteoclasts in vitro. Both compounds inhibited resorption pit formation by osteoclast-containing mixed bone cell cultures incubated for 24 h on cortical bone slices. Cell counts revealed that the inhibition was closely related to a cytotoxic effect, to which osteoclasts appeared particularly sensitive. Partial inhibition of resorption was seen in the presence of 2 microM trans-tamoxifen, whereas complete abolition of resorption and osteoclast viability occurred with 10 microM trans-tamoxifen; survival of mononuclear cells was unimpaired at either concentration. Cis-tamoxifen appeared to be slightly more toxic, with significant inhibitions of osteoclast viability and thus resorption pit formation at a concentration of 2 microM, and also of mononuclear cell numbers at 10 microM. Time-lapse video observations indicated that osteoclast death occurred rapidly (within 2-3 h) following exposure to 10 microM of either trans-tamoxifen or cis-tamoxifen. The morphological appearance of the dying cells was consistent with apoptosis. These results may help to explain the anti-resorptive action of tamoxifen seen in vivo in rats and humans. In contrast, oestradiol-17 beta consistently exerted no significant effects on resorption pit formation by rat osteoclasts over 24 h, even at grossly supraphysiological concentrations (up to 10 microM).
Similar articles
-
Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro.Br J Pharmacol. 2007 Jun;151(3):384-95. doi: 10.1038/sj.bjp.0707232. Epub 2007 Apr 10. Br J Pharmacol. 2007. PMID: 17420779 Free PMC article.
-
Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta.Nat Med. 1996 Oct;2(10):1132-6. doi: 10.1038/nm1096-1132. Nat Med. 1996. PMID: 8837613
-
Peptidomimetic antagonists of alphavbeta3 inhibit bone resorption by inhibiting osteoclast bone resorptive activity, not osteoclast adhesion to bone.J Endocrinol. 2000 Jun;165(3):587-98. doi: 10.1677/joe.0.1650587. J Endocrinol. 2000. PMID: 10828842
-
The effect of sex hormones on bone resorption by rat osteoclasts.Acta Endocrinol (Copenh). 1991 Jan;124(1):121-7. doi: 10.1530/acta.0.1240121. Acta Endocrinol (Copenh). 1991. PMID: 2000698
-
Regulation of avian osteoclastic H+ -ATPase and bone resorption by tamoxifen and calmodulin antagonists. Effects independent of steroid receptors.J Biol Chem. 1996 May 24;271(21):12488-95. doi: 10.1074/jbc.271.21.12488. J Biol Chem. 1996. PMID: 8647856
Cited by
-
CSF1R as a Therapeutic Target in Bone Diseases: Obvious but Not so Simple.Curr Osteoporos Rep. 2022 Dec;20(6):516-531. doi: 10.1007/s11914-022-00757-4. Epub 2022 Oct 5. Curr Osteoporos Rep. 2022. PMID: 36197652 Free PMC article. Review.
-
The molecular mechanism behind bone remodelling: a review.Clin Oral Investig. 2009 Dec;13(4):355-62. doi: 10.1007/s00784-009-0268-2. Epub 2009 Mar 25. Clin Oral Investig. 2009. PMID: 19319579 Review.
-
Establishment of a cell-free system of neuronal apoptosis: comparison of premitochondrial, mitochondrial, and postmitochondrial phases.J Neurosci. 1997 Aug 15;17(16):6165-78. J Neurosci. 1997. PMID: 9236228 Free PMC article.
-
Apoptosis in bone physiology and disease.Mol Pathol. 1997 Jun;50(3):132-7. doi: 10.1136/mp.50.3.132. Mol Pathol. 1997. PMID: 9292147 Free PMC article. Review. No abstract available.
-
Low-Dose Tamoxifen Induces Significant Bone Formation in Mice.JBMR Plus. 2021 Jan 20;5(3):e10450. doi: 10.1002/jbm4.10450. eCollection 2021 Mar. JBMR Plus. 2021. PMID: 33778320 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources